CCN2 and liver dysplastic nodule: HPS can potentially slow the progression of renal interstitial fibrosis in a DN model by reducing the expression of connective tissue growth factor (CTGF) and transforming growth factor-β 1 (TGF-β 1) mRNA in the kidney (Qi et al., 2015a).